1.24
4.20%
+0.05
시장 영업 전:
1.22
-0.02
-1.61%
FibroGen Inc (FGEN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
32.38%
27.14
|
40.13 | 44.32 | 36.16 | 34.37 |
Cost Of Revenue |
27.43%
5.407
|
4.243 | 5.708 | 3.491 | 4.925 |
Gross Profit |
39.45%
21.73
|
35.89 | 38.61 | 32.67 | 29.44 |
Operating Expenses
|
23.59%
75.93
|
99.37 | 126.66 | 108.76 | 95.59 |
Interest Income/Expense |
0.92%
5.068
|
5.022 | 3.069 | 2.372 | 1.119 |
Benefits Costs and Expenses |
19.59%
83.91
|
104.34 | 132.78 | 113.59 | 100.71 |
Costs And Expenses |
21.51%
81.33
|
103.62 | 132.37 | 112.25 | 100.52 |
Operating Income/Loss |
14.63%
-54.20
|
-63.48 | -88.05 | -76.09 | -66.15 |
Nonoperating Income/Loss |
41.90%
2.496
|
4.296 | 2.652 | 1.036 | 0.924 |
Income/Loss Before Equity Method Investments |
11.59%
-56.77
|
-64.21 | -88.47 | -77.43 | -66.35 |
Income/Loss From Equity Method Investments |
9.16%
0.615
|
0.677 | 0.55 | 0.796 | 0.28 |
Income/Loss From Continuing Operations Before Tax |
11.59%
-56.77
|
-64.21 | -88.47 | -77.43 | -66.35 |
Income Tax Expense/Benefit |
4.76%
0.08
|
0.084 | -0.235 | 0.074 | 0.108 |
Income/Loss From Continuing Operations After Tax |
11.58%
-56.85
|
-64.29 | -88.23 | -77.50 | -66.45 |
Net Income/Loss
|
11.61%
-56.23
|
-63.62 | -87.68 | -76.70 | -66.17 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.59%
0.402
|
98.25 | 97.73 | 94.69 | 0.151 |
Diluted Average Shares |
99.59%
0.402
|
98.25 | 97.73 | 94.69 | 0.151 |
Basic Earnings Per Share |
12.31%
-0.57
|
-0.65 | -0.90 | -0.81 | -0.71 |
Diluted Earnings Per Share |
12.31%
-0.57
|
-0.65 | -0.90 | -0.81 | -0.71 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):